{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:43:35Z","timestamp":1788911015656,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-025-03702-0","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T11:15:30Z","timestamp":1751454930000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Risk factors of bone metastasis in lung adenocarcinoma"],"prefix":"10.1186","volume":"25","author":[{"given":"Zhongnian","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengmao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"3702_CR1","doi-asserted-by":"publisher","unstructured":"Erratum. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2020;70(4):313. https:\/\/doi.org\/10.3322\/caac.21609.","DOI":"10.3322\/caac.21609"},{"issue":"11","key":"3702_CR2","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1007\/s11427-022-2240-6","volume":"66","author":"Y Wang","year":"2023","unstructured":"Wang Y, Yan Q, Fan C, et al. Overview and countermeasures of cancer burden in China. Sci China Life Sci. 2023;66(11):2515\u201326. https:\/\/doi.org\/10.1007\/s11427-022-2240-6.","journal-title":"Sci China Life Sci"},{"key":"3702_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.lungcan.2016.03.014","volume":"96","author":"MB Oliveira","year":"2016","unstructured":"Oliveira MB, Mello FC, Paschoal ME. The relationship between lung cancer histology and the clinicopathological characteristics of bone metastases. Lung Cancer. 2016;96:19\u201324. https:\/\/doi.org\/10.1016\/j.lungcan.2016.03.014.","journal-title":"Lung Cancer"},{"issue":"6","key":"3702_CR4","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3322\/caac.21695","volume":"71","author":"KD Miller","year":"2021","unstructured":"Miller KD, Ortiz AP, Pinheiro PS, et al. Cancer statistics for the US Hispanic\/Latino population, 2021. CA Cancer J Clin. 2021;71(6):466\u201387. https:\/\/doi.org\/10.3322\/caac.21695.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3702_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13045-020-00881-7","volume":"13","author":"R Chen","year":"2020","unstructured":"Chen R, Manochakian R, James L, et al. Emerging therapeutic agents for advanced non-smallcell lung cancer. J Hematol Oncol. 2020;13(1):58. https:\/\/doi.org\/10.1186\/s13045-020-00881-7.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"3702_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3760\/cma.j.issn.0253-3766.2019.01.005","volume":"41","author":"RS Zheng","year":"2019","unstructured":"Zheng RS, Sun KX, Zhang SW, et al. [Report of cancer epidemiology in China, 2015]. Zhonghua Zhong Liu Za Zhi. 2019;41(1):19\u201328. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-3766.2019.01.005. Chinese.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"3702_CR7","doi-asserted-by":"publisher","first-page":"1392667","DOI":"10.3389\/fonc.2024.1392667","volume":"14","author":"BJ Knapp","year":"2024","unstructured":"Knapp BJ, Cittolin-Santos GF, Flanagan ME, et al. Incidence and risk factors for bone metastases at presentation in solid tumors. Front Oncol. 2024;14:1392667. https:\/\/doi.org\/10.3389\/fonc.2024.1392667.","journal-title":"Front Oncol"},{"key":"3702_CR8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.lungcan.2021.09.008","volume":"161","author":"N Barany","year":"2021","unstructured":"Barany N, Rozsas A, Megyesfalvi Z, et al. Clinical relevance of Circulating activin A and follistatin in small cell lung cancer. Lung Cancer. 2021;161:128\u201335. https:\/\/doi.org\/10.1016\/j.lungcan.2021.09.008.","journal-title":"Lung Cancer"},{"issue":"3","key":"3702_CR9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/cancers17030559","volume":"17","author":"Y Liu","year":"2025","unstructured":"Liu Y, Shen S, Wang X, et al. GATA3-Driven CeRNA network in lung adenocarcinoma bone metastasis progression and therapeutic implications. Cancers (Basel). 2025;17(3):559.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"3702_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1081\/BIP-120028503","volume":"14","author":"G Williams","year":"2004","unstructured":"Williams G, Pazdur R, Temple R. Assessing Tumor-Related signs and symptoms to support Cancer drug approval. J Biopharm Stat. 2004;14(1):5\u201321. https:\/\/doi.org\/10.1081\/BIP-120028503.","journal-title":"J Biopharm Stat"},{"issue":"5","key":"3702_CR11","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.21037\/jtd-21-1502","volume":"14","author":"BJ Knapp","year":"2022","unstructured":"Knapp BJ, Devarakonda S, Govindan R. Bone metastases in non-small cell lung cancer: a narrative review. J Thorac Dis. 2022;14(5):1696\u2013712. https:\/\/doi.org\/10.21037\/jtd-21-1502.","journal-title":"J Thorac Dis"},{"issue":"4","key":"3702_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3779\/j.issn.1009-3419.2019","volume":"22","author":"Beijing Medical Award Foundation Young Expert Committee on Lung Cancer, Chinese Alliance for Thoracic Surgery Lung Cancer","year":"2019","unstructured":"Beijing Medical Award Foundation Young Expert Committee on Lung Cancer, Chinese Alliance for Thoracic Surgery Lung Cancer. Expert consensus on the diagnosis and treatment of bone metastases from lung Cancer (2019 Edition). Chin J Lung Cancer. 2019;22(4):187\u2013207. https:\/\/doi.org\/10.3779\/j.issn.1009-3419.2019. 04. 01.","journal-title":"Chin J Lung Cancer"},{"issue":"9","key":"3702_CR13","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Nicholson AG, et al. The 2015 world health organization classification of lung tumors: Lmpact of genetic, clinical and radiologic advances sincethe 2004 classification. JThorac Oncol. 2015;10(9):1243\u201360. https:\/\/doi.org\/10.1097\/JTO.0000000000000630.","journal-title":"JThorac Oncol"},{"issue":"7","key":"3702_CR14","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1016\/S1470-2045(20)30073-5","volume":"21","author":"W Wei","year":"2020","unstructured":"Wei W, Zeng H, Zheng R, et al. Cancer registration in China and its role in cancer prevention and control. Lancet Oncol. 2020;21(7):e342\u20139. https:\/\/doi.org\/10.1016\/S1470-2045(20)30073-5.","journal-title":"Lancet Oncol"},{"issue":"1","key":"3702_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CEJ.0000000000000635","volume":"31","author":"E Rizzello","year":"2022","unstructured":"Rizzello E, Denti Pompiani I, Violante F, et al. Interaction between occupational exposure to diesel exhaust and tobacco smoking in determining lung cancer risk: a meta-analysis. Eur J Cancer Prev. 2022;31(1):1\u20136. https:\/\/doi.org\/10.1097\/CEJ.0000000000000635.","journal-title":"Eur J Cancer Prev"},{"key":"3702_CR16","doi-asserted-by":"publisher","first-page":"1177482","DOI":"10.3389\/fonc.2023.1177482","volume":"13","author":"J Long","year":"2023","unstructured":"Long J, Zhai M, Jiang Q, et al. The incidence and mortality of lung cancer in China: a trend analysis and comparison with G20 based on the global burden of disease study 2019. Front Oncol. 2023;13:1177482. https:\/\/doi.org\/10.3389\/fonc.2023.1177482.","journal-title":"Front Oncol"},{"issue":"2","key":"3702_CR17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.7314\/apjcp.2016.17.2.557","volume":"17","author":"Z Almasi","year":"2016","unstructured":"Almasi Z, Salehiniya H, Amoori N, et al. Epidemiology characteristics and trends of lung Cancer incidence in Iran. Asian Pac J Cancer Prev. 2016;17(2):557\u201362. https:\/\/doi.org\/10.7314\/apjcp.2016.17.2.557.","journal-title":"Asian Pac J Cancer Prev"},{"key":"3702_CR18","doi-asserted-by":"publisher","unstructured":"Li Yuan Y, Zhigang. Tumor doubling time characteristics and pathological basis of lung cancer. J Biomed Eng. 2009;26(6):1388\u201390. https:\/\/doi.org\/10.3321\/j.issn:1001-5515.2009.06.048.","DOI":"10.3321\/j.issn:1001-5515.2009.06.048"},{"issue":"10","key":"3702_CR19","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.1007\/s00330-018-5857-5","volume":"29","author":"CI Henschke","year":"2019","unstructured":"Henschke CI, Yip R, Ma T, et al. CT screening for lung cancer: comparison of three baseline screening protocols. Eur Radiol. 2019;29(10):5217\u201326. https:\/\/doi.org\/10.1007\/s00330-018-5857-5.","journal-title":"Eur Radiol"},{"issue":"2","key":"3702_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/1354750X.2024.2319702","volume":"29","author":"Y Song","year":"2024","unstructured":"Song Y, Li H, Jiang Q, et al. Prognostic and clinicopathological value of osteopontin expression in non-small cell lung cancer: a meta-analysis and systematic review. Biomarkers. 2024;29(2):105\u201313. https:\/\/doi.org\/10.1080\/1354750X.2024.2319702.","journal-title":"Biomarkers"},{"issue":"12","key":"3702_CR21","doi-asserted-by":"publisher","first-page":"107138","DOI":"10.1016\/j.ejso.2023.107138","volume":"49","author":"R Wang","year":"2023","unstructured":"Wang R, Xu B, Sun M, et al. Dynamic monitoring of serum CEA and CA19-9 predicts the prognosis of postoperative stage II colon cancer. Eur J Surg Oncol. 2023;49(12):107138. https:\/\/doi.org\/10.1016\/j.ejso.2023.107138.","journal-title":"Eur J Surg Oncol"},{"issue":"5\u20136","key":"3702_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.14740\/wjon1163","volume":"9","author":"M Tomita","year":"2018","unstructured":"Tomita M, Ayabe T, Maeda R, et al. Serum carcinoembryonic antigen level predicts Cancer-Specific outcomes of resected Non-Small cell lung Cancer with interstitial pneumonia. World J Oncol. 2018;9(5\u20136):136\u201340. https:\/\/doi.org\/10.14740\/wjon1163.","journal-title":"World J Oncol"},{"issue":"7","key":"3702_CR23","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1111\/1759-7714.13449","volume":"11","author":"C de Jong","year":"2020","unstructured":"de Jong C, Deneer VHM, Kelder JC, et al. Association between serum biomarkers CEA and LDH and response in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Thorac Cancer. 2020;11(7):1790\u2013800. https:\/\/doi.org\/10.1111\/1759-7714.13449.","journal-title":"Thorac Cancer"},{"issue":"4","key":"3702_CR24","doi-asserted-by":"publisher","first-page":"20200005","DOI":"10.1515\/almed-2020-0005","volume":"1","author":"S Garcia-Valdecasas Gayo","year":"2020","unstructured":"Garcia-Valdecasas Gayo S, Ruiz-Alvarez MJ, Gonzalez-Gay D, et al. CYFRA 21\u2013\u20091 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value. Adv Lab Med. 2020;1(4):20200005. https:\/\/doi.org\/10.1515\/almed-2020-0005.","journal-title":"Adv Lab Med"},{"issue":"3","key":"3702_CR25","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/pros.20540","volume":"67","author":"A Ramankulov","year":"2007","unstructured":"Ramankulov A, Lein M, Kristiansen G, et al. Plasma osteopontin in comparison with bone markers as indicator of bone metastasis and survival outcome in patients with prostate cancer. Prostate. 2007;67(3):330\u201340. https:\/\/doi.org\/10.1002\/pros.20540.","journal-title":"Prostate"},{"key":"3702_CR26","unstructured":"Zhang Ping W, Xiaonan N, Xin, et al. EGFR gene mutation and clinical characteristics of advanced lung adenocarcinoma. Practical J Oncol. 2018;33(2):150\u20133."},{"issue":"3","key":"3702_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1001\/jamaoncol.2015.4482","volume":"2","author":"AG Sacher","year":"2016","unstructured":"Sacher AG, Dahlberg SE, Heng J, et al. Association between younger age and targetable genomic alterations and prognosis in Non-Small-Cell lung Cancer. JAMA Oncol. 2016;2(3):313\u201320. https:\/\/doi.org\/10.1001\/jamaoncol.2015.4482.","journal-title":"JAMA Oncol"},{"key":"3702_CR28","doi-asserted-by":"publisher","unstructured":"He Rongzhi L, Chuan C, Jing, et al. EGFR gene mutation analysis in non-small cell lung cancer tissues, blood and pleural fluid. J Clin Experimental Pathol. 2019;35(04):48\u201351. https:\/\/doi.org\/10.13315\/j.cnki.cjcep.2019.04.010.","DOI":"10.13315\/j.cnki.cjcep.2019.04.010"},{"issue":"12 Pt 2","key":"3702_CR29","doi-asserted-by":"publisher","first-page":"s4227","DOI":"10.1158\/1078-0432","volume":"10","author":"GV Scagliotti","year":"2004","unstructured":"Scagliotti GV, Selvaggi G, Novello S, et al. The biology of epidermal growth factor receptor in lung cancer. Clin Cancer Res. 2004;10(12 Pt 2):s4227\u201332. https:\/\/doi.org\/10.1158\/1078-0432.","journal-title":"Clin Cancer Res"},{"key":"3702_CR30","doi-asserted-by":"crossref","unstructured":"Larsen AK, Ouaret D, El Ouadrani K et al. Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis. Pharmacol Ther. 2011; 131(1): 80\u201390. doi: 10. 1016\/j.pharmthera.2011.03.012.","DOI":"10.1016\/j.pharmthera.2011.03.012"},{"issue":"1","key":"3702_CR31","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1038\/s41598-017-03460-y","volume":"7","author":"S Tavera","year":"2017","unstructured":"Tavera S, Pucci M, Giallombardo M, et al. Amphiregulin contained in NSCLC-exosomes induces osteoclast differentiation through the activation of EGFR pathway. Sci Rep. 2017;7(1):3170. https:\/\/doi.org\/10.1038\/s41598-017-03460-y.","journal-title":"Sci Rep"},{"key":"3702_CR32","doi-asserted-by":"publisher","unstructured":"Oh JE, Chung HS, Gwon HR et al. Prediction of lymph node metastasis in lung Cancer using deep learning of endobronchial ultrasound images with size on CT and PET-CT findings. Respirology. 2025 Mar 3. https:\/\/doi.org\/10.1111\/resp.70010","DOI":"10.1111\/resp.70010"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03702-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03702-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03702-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T11:15:36Z","timestamp":1751454936000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-03702-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3702"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03702-0","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"11 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the ethics committee of National Cancer Center\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College(No. 23\/167\u20133909).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"299"}}